276 related articles for article (PubMed ID: 26554380)
1. Mutational Profiling Can Establish Clonal or Independent Origin in Synchronous Bilateral Breast and Other Tumors.
Bao L; Messer K; Schwab R; Harismendy O; Pu M; Crain B; Yost S; Frazer KA; Rana B; Hasteh F; Wallace A; Parker BA
PLoS One; 2015; 10(11):e0142487. PubMed ID: 26554380
[TBL] [Abstract][Full Text] [Related]
2. Uncovering the genomic heterogeneity of multifocal breast cancer.
Desmedt C; Fumagalli D; Pietri E; Zoppoli G; Brown D; Nik-Zainal S; Gundem G; Rothé F; Majjaj S; Garuti A; Carminati E; Loi S; Van Brussel T; Boeckx B; Maetens M; Mudie L; Vincent D; Kheddoumi N; Serra L; Massa I; Ballestrero A; Amadori D; Salgado R; de Wind A; Lambrechts D; Piccart M; Larsimont D; Campbell PJ; Sotiriou C
J Pathol; 2015 Aug; 236(4):457-66. PubMed ID: 25850943
[TBL] [Abstract][Full Text] [Related]
3. Whole-Exome Sequencing Analysis of the Progression from Non-Low-Grade Ductal Carcinoma
Pareja F; Brown DN; Lee JY; Da Cruz Paula A; Selenica P; Bi R; Geyer FC; Gazzo A; da Silva EM; Vahdatinia M; Stylianou AA; Ferrando L; Wen HY; Hicks JB; Weigelt B; Reis-Filho JS
Clin Cancer Res; 2020 Jul; 26(14):3682-3693. PubMed ID: 32220886
[TBL] [Abstract][Full Text] [Related]
4. Oncotype DX in Bilateral Synchronous Primary Invasive Breast Cancer.
Karsten M; Stempel M; Radosa J; Patil S; King TA
Ann Surg Oncol; 2016 Feb; 23(2):471-6. PubMed ID: 26340863
[TBL] [Abstract][Full Text] [Related]
5. Clonal relatedness in tumour pairs of breast cancer patients.
Biermann J; Parris TZ; Nemes S; Danielsson A; Engqvist H; Werner Rönnerman E; Forssell-Aronsson E; Kovács A; Karlsson P; Helou K
Breast Cancer Res; 2018 Aug; 20(1):96. PubMed ID: 30092821
[TBL] [Abstract][Full Text] [Related]
6. Genetic Heterogeneity in Therapy-Naïve Synchronous Primary Breast Cancers and Their Metastases.
Ng CKY; Bidard FC; Piscuoglio S; Geyer FC; Lim RS; de Bruijn I; Shen R; Pareja F; Berman SH; Wang L; Pierga JY; Vincent-Salomon A; Viale A; Norton L; Sigal B; Weigelt B; Cottu P; Reis-Filho JS
Clin Cancer Res; 2017 Aug; 23(15):4402-4415. PubMed ID: 28351929
[No Abstract] [Full Text] [Related]
7. Multigene clinical mutational profiling of breast carcinoma using next-generation sequencing.
Roy-Chowdhuri S; de Melo Gagliato D; Routbort MJ; Patel KP; Singh RR; Broaddus R; Lazar AJ; Sahin A; Alvarez RH; Moulder S; Wheler JJ; Janku F; Gonzalez-Angulo AM; Chavez-MacGregor M; Valero V; Ueno NT; Mills G; Mendelsohn J; Yao H; Aldape K; Luthra R; Meric-Bernstam F
Am J Clin Pathol; 2015 Nov; 144(5):713-21. PubMed ID: 26486734
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic and prognostic utility of molecular markers in synchronous bilateral breast carcinoma.
Saad RS; Denning KL; Finkelstein SD; Liu Y; Pereira TC; Lin X; Silverman JF
Mod Pathol; 2008 Oct; 21(10):1200-7. PubMed ID: 18469799
[TBL] [Abstract][Full Text] [Related]
9. A metastasis or a second independent cancer? Evaluating the clonal origin of tumors using array copy number data.
Ostrovnaya I; Olshen AB; Seshan VE; Orlow I; Albertson DG; Begg CB
Stat Med; 2010 Jul; 29(15):1608-21. PubMed ID: 20205270
[TBL] [Abstract][Full Text] [Related]
10. Genomic and mutational profiling to assess clonal relationships between multiple non-small cell lung cancers.
Girard N; Ostrovnaya I; Lau C; Park B; Ladanyi M; Finley D; Deshpande C; Rusch V; Orlow I; Travis WD; Pao W; Begg CB
Clin Cancer Res; 2009 Aug; 15(16):5184-90. PubMed ID: 19671847
[TBL] [Abstract][Full Text] [Related]
11. High-resolution mapping of DNA breakpoints to define true recurrences among ipsilateral breast cancers.
Bollet MA; Servant N; Neuvial P; Decraene C; Lebigot I; Meyniel JP; De Rycke Y; Savignoni A; Rigaill G; Hupé P; Fourquet A; Sigal-Zafrani B; Barillot E; Thiery JP
J Natl Cancer Inst; 2008 Jan; 100(1):48-58. PubMed ID: 18159071
[TBL] [Abstract][Full Text] [Related]
12. Comparative genomic analysis reveals bilateral breast cancers are genetically independent.
Song F; Li X; Song F; Zhao Y; Li H; Zheng H; Gao Z; Wang J; Zhang W; Chen K
Oncotarget; 2015 Oct; 6(31):31820-9. PubMed ID: 26378809
[TBL] [Abstract][Full Text] [Related]
13. Efficacious diagnosis of primary and metastatic human carcinomas with a combination of p53 mutation analysis and clonality analysis of androgen receptor gene.
Aotake T; Muraoka R; Matsukawa S; Tanigawa N
Int J Oncol; 1998 Oct; 13(4):773-9. PubMed ID: 9735408
[TBL] [Abstract][Full Text] [Related]
14. Molecular profiling identifies synchronous endometrial and ovarian cancers as metastatic endometrial cancer with favorable clinical outcome.
Reijnen C; Küsters-Vandevelde HVN; Ligtenberg MJL; Bulten J; Oosterwegel M; Snijders MPLM; Sweegers S; de Hullu JA; Vos MC; van der Wurff AAM; van Altena AM; Eijkelenboom A; Pijnenborg JMA
Int J Cancer; 2020 Jul; 147(2):478-489. PubMed ID: 32022266
[TBL] [Abstract][Full Text] [Related]
15. Revisiting multifocal breast cancer: a clonality study of ductal carcinoma using whole exome sequencing.
Schwartz CJ; Dolgalev I; Vasudevaraja V; Kelly S; Heguy A; Snuderl M; Cotzia P; Jour G; Darvishian F
Hum Pathol; 2019 Dec; 94():71-77. PubMed ID: 31704365
[TBL] [Abstract][Full Text] [Related]
16. Factors influencing the hormone receptor and HER2 levels in breast cancer: a population-based analysis.
Tas F
Onkologie; 2012; 35(3):95-8. PubMed ID: 22414972
[TBL] [Abstract][Full Text] [Related]
17. PIK3CA mutations mostly begin to develop in ductal carcinoma of the breast.
Li H; Zhu R; Wang L; Zhu T; Li Q; Chen Q; Wang H; Zhu H
Exp Mol Pathol; 2010 Feb; 88(1):150-5. PubMed ID: 19818761
[TBL] [Abstract][Full Text] [Related]
18. Exome sequencing of contralateral breast cancer identifies metastatic disease.
Klevebring D; Lindberg J; Rockberg J; Hilliges C; Hall P; Sandberg M; Czene K
Breast Cancer Res Treat; 2015 Jun; 151(2):319-24. PubMed ID: 25922084
[TBL] [Abstract][Full Text] [Related]
19. Histopathological criteria and selection algorithms for BRCA1 genetic testing.
Gadzicki D; Schubert A; Fischer C; Milde S; Lehmann U; Steinemann D; Lück HJ; Kreipe H; Schlegelberger B
Cancer Genet Cytogenet; 2009 Mar; 189(2):105-11. PubMed ID: 19215791
[TBL] [Abstract][Full Text] [Related]
20. A molecular genetic and statistical approach for the diagnosis of dual-site cancers.
Brinkmann D; Ryan A; Ayhan A; McCluggage WG; Feakins R; Santibanez-Koref MF; Mein CA; Gayther SA; Jacobs IJ
J Natl Cancer Inst; 2004 Oct; 96(19):1441-6. PubMed ID: 15467033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
